Wenge Lu
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
- Oncology 11
- Cancer-related Molecular Pathways 9
-
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 2
- Co-authors
- Jiandong Chen (7 shared papers)Yanhua Peng (3 shared papers)Lihong Chen (3 shared papers)Run Yu (2 shared papers)Шломо Мелмед (2 shared papers)Changgong Li (3 shared papers)Robert D. Christensen (7 shared papers)Akhil Maheshwari (7 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Cytokine (2 papers)Oncogene (2 papers)Pediatric Research (2 papers)Neonatology (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Wenge Lu
19 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Oncology 464
- Biotechnology 96
- Cancer Research 125
- Endocrinology, Diabetes and Metabolism 134
- Cell Biology 129
Countries citing papers authored by Wenge Lu
This map shows the geographic impact of Wenge Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Lu more than expected).
Fields of papers citing papers by Wenge Lu
This network shows the impact of papers produced by Wenge Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Lu. The network helps show where Wenge Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenge Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 159 | |
| 2 | 2003 | 111 | |
| 3 | 2000 | 103 | |
| 4 | 2001 | 96 | |
| 5 | 2000 | 76 | |
| 6 | 2004 | 66 | |
| 7 | 1999 | 66 | |
| 8 | 2002 | 63 | |
| 9 | 1999 | 61 | |
| 10 | 2001 | 57 | |
| 11 | 2004 | 39 | |
| 12 | Expression of p14ARF overcomes tumor resistance to p53. | 2002 | 32 |
| 13 | 2005 | 30 | |
| 14 | 2003 | 29 | |
| 15 | 2008 | 29 | |
| 16 | 2005 | 14 | |
| 17 | 2000 | 13 | |
| 18 | 2004 | 7 | |
| 19 | 2021 | 7 |
About Wenge Lu
Wenge Lu is a scholar working on Oncology, Molecular Biology, Biotechnology, Cell Biology and Nutrition and Dietetics, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Cancer Research and Treatments (6 papers), Ubiquitin and proteasome pathways (3 papers), Infant Nutrition and Health (3 papers), Immune Response and Inflammation (3 papers), Microtubule and mitosis dynamics (2 papers), Neonatal Respiratory Health Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (464 citations), Biotechnology (96 citations), Cancer Research (125 citations), Endocrinology, Diabetes and Metabolism (134 citations) and Cell Biology (129 citations). Wenge Lu has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Jiandong Chen, Yanhua Peng, Lihong Chen, Run Yu, Шломо Мелмед, Changgong Li, Robert D. Christensen, Akhil Maheshwari, Darlene A Calhoun and Radhika Pochampally. Their work appears in journals such as Journal of Biological Chemistry, Cytokine, Oncogene, Pediatric Research and Neonatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.